According to Pharmanutra's latest financial reports the company has a price-to-book ratio of 4.25701.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 8.39 | -15.83% |
2023-12-31 | 9.97 | -15.54% |
2022-12-31 | 11.8 | -27.11% |
2021-12-31 | 16.2 | 67.83% |
2020-12-31 | 9.65 | 19.82% |
2019-12-31 | 8.05 | 34.63% |
2018-12-31 | 5.98 | 29.41% |
2017-12-31 | 4.62 | |
2016-12-31 | N/A |